deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT04342663

A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection (STOP COVID)

Sponsor: Washington University School of Medicine

Conditions COVID 19 Coronavirus
Interventions Fluvoxamine Placebo
Updated 13 times since 2020 Last updated: Jul 7, 2021 Started: Apr 10, 2020 Primary completion: Aug 20, 2020 Completion: Dec 12, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on COVID 19 and Coronavirus, this trial is completed. The trial is conducted by Washington University School of Medicine and has accumulated 13 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Sep 2020 · 3 months · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

▶ Show 8 earlier versions

  1. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE2

  2. Sep 2021 — Dec 2021 [monthly]

    Completed PHASE2

  3. Feb 2021 — Sep 2021 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE2

  5. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  6. Sep 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  7. Jun 2020 — Sep 2020 [monthly]

    Recruiting PHASE2

  8. May 2020 — Jun 2020 [monthly]

    Recruiting PHASE2

    First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Washington University School of Medicine
Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations